Jeffrey B. Mirviss, EVP&Pres, Periph Intervent at BOSTON SCIENTIFIC CORP (BSX), sold 23,862 shares at $57.82 ($1.4M) on 2024-01-03, disclosed to the SEC on 2024-01-04.
Scheduled sale ($1.4M) by EVP&Pres, Periph Intervent under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.82 | 11,931 | $690K | 50.0% |
| 2 | $57.82 | 11,931 | $690K | 50.0% |
| Total | $57.82 avg | 23,862 | $1.4M | 100% |
| Filing → |
| BSX | SELL | 2025-02-13 | $2.7M | — | Filing → |
| BSX | SELL | 2025-01-03 | $1.3M | — | Filing → |
| BSX | SELL | 2024-05-30 | $9.6M | — | Filing → |